Biomarkers of progressive lung fibrosis

QR Code

Biomarkers of progressive lung fibrosis

Interstitial lung diseases (ILD) encompass a heterogeneous group of immuno-inflammatory and fibrotic diseases of the lung parenchyma. The most common and severe ILD is idiopathic pulmonary fibrosis (IPF), a chronic progressive fibrotic lung disease of unknown aetiology associated with poor prognosis...

Full description

Bibliographic Details
Main Author:	Khan, Fasihul
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2022
Subjects:	Interstitial lung diseases; Progressive fibrosis; Clinical biomarkers; Fibrotic phenotypes
Online Access:	https://eprints.nottingham.ac.uk/67514/

Similar Items

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
by: Maher, Toby M., et al.
Published: (2017)

Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
by: Hutchinson, John P., et al.
Published: (2016)

In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011
by: Hutchinson, John P., et al.
Published: (2016)

The role of Interleukin-33 in the development of idiopathic pulmonary fibrosis
by: Stephenson, Katherine
Published: (2021)

Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)
by: Barratt, Shaney L., et al.
Published: (2018)

Biomarkers to predict advanced liver diseases
by: Alenezi, Yusef
Published: (2024)

Refining in-vivo models of pulmonary fibrosis
by: Habgood, Anthony
Published: (2018)

Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study
by: Forrester, Doug L., et al.
Published: (2013)

Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)

The role of mesenchymal G proteins in pulmonary fibrosis and lung development
by: Goodwin, Amanda T.
Published: (2021)

Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?
by: O'Dowd, Emma L., et al.
Published: (2015)

The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study
by: Donaldson, J.W., et al.
Published: (2014)

What is the risk of progressive multifocal leukoencephalopathy in patients with ulcerative colitis or Crohn’s Disease treated with vedolizumab?
by: Card, Timothy R., et al.
Published: (2018)

Nephronectin and the genetics of lung function variability
by: Qian, Guoqing
Published: (2023)

Interplay between EZH2 and G9a regulates CXCL10 gene repression in idiopathic pulmonary fibrosis
by: Coward, William R., et al.
Published: (2017)

Application of autoantibody binding curve characteristics and machine learning methods for improving the diagnostic performance of an early detection test for lung cancer
by: Allen, Jared
Published: (2023)

International comparative epidemiology of idiopathic pulmonary fibrosis
by: Hutchinson, John
Published: (2017)

Herbal and dietary supplement use in Thai patients with chronic kidney disease (CKD) and their association with progression of CKD
by: Tangkiatkumjai, Mayuree
Published: (2014)

Spatiotemporal regulation of anti-remodelling signalling pathways in primary human lung fibroblasts
by: Roberts, Maxine
Published: (2020)

Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)

THE IDENTIFICATION OF BIOMARKERS TO PREDICT RESPONSE TO TREATMENTS IN ASTHMA
by: Lissa, Sutherland
Published: (2019)

Optimisation of xenon-rich stopped-flow spin-exchange optical pumping for functional lung imaging
by: Skinner, J.G.
Published: (2017)

Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients
by: Ravipati, Srinivasarao, et al.
Published: (2015)

Shrinking Lung Syndrome – A rare cause of recurrent dyspnoea in SLE / Hazlyna Baharuddin … [et al.]
by: Baharuddin, Hazlyna, et al.
Published: (2017)

Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial
by: Sullivan, Frank M., et al.
Published: (2017)

sTREM-1 is elevated in cystic fibrosis and correlates with proteases
by: Forrester, D.L., et al.
Published: (2017)

A systematic review to identify how the current clinical trials landscape reflects the James Lind Alliance top 10 research priorities for cystic fibrosis
by: Kalaitzis, I.S., et al.
Published: (2018)

Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
by: Thomson, E., et al.
Published: (2010)

Proteomic and transcriptomic analyses of protein biomarkers during early hyperinfection in strongyloidiasis
by: Al-Zihiry, Khalid Jameel Kadhim
Published: (2016)

Suberoylanilide hydroxamic acid – a potential epigenetic therapeutic agent for lung fibrosis?
by: Wang, Z., et al.
Published: (2009)

Factors influencing the diagnosis and subsequent prognosis in patients with lung cancer
by: O'Dowd, Emma Louise
Published: (2017)

A study on biomarkers in workers exposure to benzene
by: Cao, J., et al.
Published: (2002)

Significance of subcentimetre 18F-FDG PET/CT pulmonary abnormality in patients with known extrapulmonary malignancy.
by: Ahmad Saad , Fathinul Fikri, et al.
Published: (2010)

Lung mechanics and hyperpolarised gas MRI
by: Thorpe, James
Published: (2018)

Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa
by: Spencer, Daniella Lucy
Published: (2019)

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
by: Hutchinson, John P., et al.
Published: (2015)

Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
by: Jenkins, R. Gisli, et al.
Published: (2015)